Chinese robotics companies experienced a significant boost in stock prices following the release of new guidance from officials. Analysts believe that this move indicates forthcoming supportive policies for the humanoid robots industry. A number of companies in the sector saw gains in early trading on mainland bourses, with Guangzhou Haozhi Industrial and Ningbo Zhongda Leader Intelligent Transmission soaring by their daily limits, adding 20% and 10%, respectively.
China’s Ministry of Industry and Information Technology recently unveiled a comprehensive guidance that includes three- and five-year strategic plans for the development of humanoid robots. The ministry’s stated goal is to “cultivate” two to three companies that will become global industry leaders by 2025, while encouraging other small and medium-sized companies to specialize in the field. Additionally, the guidance calls for the establishment of a reliable supply chain by 2027.
Chinese companies primarily focus on manufacturing key parts of humanoid robots, such as motors, sensors, reduction gears, and encoders. However, there are only a few domestic companies currently producing complete humanoid robots. The new guidance from the government is expected to stimulate the growth of the industry and create opportunities for localization of the production of core components and high-end equipment.
Analysts from Citic Securities, including Ruipeng Li and Haibo Liu, suggest that the government’s guidance indicates further refinement in the development of the industry. They believe that this direction will effectively stimulate and support China’s humanoid robot industry, highlighting Harbin Boshi Automation, Xiaomi, and XPeng as companies with the potential to benefit from the government’s goals.
Orient Securities analyst Zhen Yang expressed optimism about the sector’s development, stating that there are accelerating opportunities for localizing the production of core components. Similarly, analysts Wei Deng and Baolai You from Huafu Securities view the government’s guidance as a crucial milestone for technology competition, believing that it will boost supply-chain development.
Overall, the release of new guidance from Chinese officials has sparked a surge in stock prices for robotics companies. This indicates growing expectations for supportive policies and the development of the humanoid robots industry in China.
FAQ
1. What is the recent guidance released by Chinese officials?
The Chinese Ministry of Industry and Information Technology released a guidance that includes three- and five-year strategic plans for developing humanoid robots. The guidance aims to cultivate leading companies in the global industry and establish a reliable supply chain.
2. How did Chinese robotics companies’ stock prices respond to the guidance?
Following the release of the guidance, several Chinese robotics companies experienced a significant increase in stock prices. Guangzhou Haozhi Industrial and Ningbo Zhongda Leader Intelligent Transmission saw their stock prices rise by their daily limits of 20% and 10%, respectively.
3. What are the key areas of focus for Chinese companies in the robotics industry?
Chinese companies primarily specialize in manufacturing key parts for humanoid robots, such as motors, sensors, reduction gears, and encoders. However, there are currently only a few domestic companies producing complete humanoid robots.
4. Which companies are expected to benefit from the government’s goals?
Analysts from Citic Securities highlight Harbin Boshi Automation, Xiaomi, and XPeng as companies with the capacity to develop humanoid robots and benefit from the government’s objectives of achieving global success in the field.
5. How do analysts perceive the government’s guidance?
Analysts express optimism and believe that the new guidance will effectively stimulate and support China’s humanoid robot industry. They see it as a new high ground for technology competition and expect it to accelerate opportunities for localizing the production of core components and high-end equipment.